Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis
- PMID: 15673762
- PMCID: PMC547225
- DOI: 10.1128/AAC.49.2.767-769.2005
Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis
Abstract
Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)-resistant Candida strain during therapy.
Similar articles
-
Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00651-17. doi: 10.1128/AAC.00651-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28630186 Free PMC article.
-
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.Mycoses. 2015 Apr;58(4):209-14. doi: 10.1111/myc.12299. Epub 2015 Feb 27. Mycoses. 2015. PMID: 25727853
-
Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr.Int J Antimicrob Agents. 2004 May;23(5):520-3. doi: 10.1016/j.ijantimicag.2003.10.005. Int J Antimicrob Agents. 2004. PMID: 15120736
-
Resistance of Candida to azoles and echinocandins worldwide.Clin Microbiol Infect. 2019 Jul;25(7):792-798. doi: 10.1016/j.cmi.2019.03.028. Epub 2019 Apr 6. Clin Microbiol Infect. 2019. PMID: 30965100 Review.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Antifungal effect of 4-arylthiosemicarbazides against Candida species. Search for molecular basis of antifungal activity of thiosemicarbazide derivatives.J Mol Model. 2012 Sep;18(9):4159-70. doi: 10.1007/s00894-012-1420-5. Epub 2012 Apr 26. J Mol Model. 2012. PMID: 22535361 Free PMC article.
-
Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin.Antimicrob Agents Chemother. 2006 Feb;50(2):744-7. doi: 10.1128/AAC.50.2.744-747.2006. Antimicrob Agents Chemother. 2006. PMID: 16436735 Free PMC article.
-
High prevalence of itraconazole resistance among Candida parapsilosis isolated from Iran.Curr Med Mycol. 2019 Sep;5(3):43-46. doi: 10.18502/cmm.5.3.1746. Curr Med Mycol. 2019. PMID: 31850396 Free PMC article.
-
Candida parapsilosis endocarditis: a comparative review of the literature.Eur J Clin Microbiol Infect Dis. 2007 Dec;26(12):915-26. doi: 10.1007/s10096-007-0386-1. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17805589 Review.
-
Parallel and cross-resistances of clinical yeast isolates determined by susceptibility pattern analysis.GMS Infect Dis. 2016 Jun 7;4:Doc02. doi: 10.3205/id000020. eCollection 2016. GMS Infect Dis. 2016. PMID: 30671316 Free PMC article.
References
-
- Abu-el Teen, K., M. Ghannoum, and R. J. Stretton. 1989. Effects of sub-inhibitory concentrations of antifungal agents on adherence of Candida spp. to buccal epithelial cells in vitro. Mycoses 32:551-562. - PubMed
-
- Denning, D. W. 2002. Echinocandins: a new class of antifungal. J. Antimicrob. Chemother. 49:889-891. - PubMed
-
- Diekema, D. J., S. A. Messer, R. J. Hollis, R. P. Wenzel, and M. A. Pfaller. 1997. An outbreak of Candida parapsilosis prosthetic valve endocarditis. Diagn. Microbiol. Infect. Dis. 29:147-153. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous